First Time Loading...
V

VIVA Biotech Holdings
HKEX:1873

Watchlist Manager
VIVA Biotech Holdings
HKEX:1873
Watchlist
Price: 0.61 HKD Market Closed
Updated: May 3, 2024

Income Statement

Earnings Waterfall
VIVA Biotech Holdings

Revenue
2.2B CNY
Cost of Revenue
-1.4B CNY
Gross Profit
738.4m CNY
Operating Expenses
-527.4m CNY
Operating Income
211.1m CNY
Other Expenses
-327.2m CNY
Net Income
-116.1m CNY

Income Statement
VIVA Biotech Holdings

Rotate your device to view
Income Statement
Currency: CNY
Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
697
N/A
1 526
+119%
2 104
+38%
2 186
+4%
2 380
+9%
2 413
+1%
2 156
-11%
Gross Profit
Cost of Revenue
(392)
(1 005)
(1 453)
(1 507)
(1 564)
(1 536)
(1 417)
Gross Profit
305
N/A
521
+71%
651
+25%
680
+4%
816
+20%
877
+7%
738
-16%
Operating Income
Operating Expenses
(215)
(335)
(391)
(431)
(520)
(556)
(527)
Selling, General & Administrative
(123)
(219)
(320)
(384)
(404)
(410)
(410)
Research & Development
(66)
(81)
(92)
(96)
(136)
(172)
(128)
Other Operating Expenses
(26)
(34)
22
48
20
25
10
Operating Income
90
N/A
186
+108%
260
+40%
249
-4%
295
+19%
321
+9%
211
-34%
Pre-Tax Income
Interest Income Expense
92
42
(59)
(253)
(715)
(627)
(434)
Non-Reccuring Items
9
4
9
6
(50)
(53)
(8)
Total Other Income
(547)
55
137
161
10
0
174
Pre-Tax Income
(356)
N/A
288
N/A
348
+21%
162
-53%
(459)
N/A
(359)
+22%
(56)
+84%
Net Income
Tax Provision
(23)
(41)
(47)
(43)
(45)
(46)
(44)
Income from Continuing Operations
(379)
247
301
120
(504)
(405)
(100)
Income to Minority Interest
(8)
(19)
(13)
(8)
(24)
(31)
(16)
Net Income (Common)
(387)
N/A
228
N/A
288
+26%
111
-61%
(528)
N/A
(436)
+17%
(116)
+73%
EPS (Diluted)
-0.25
N/A
0.13
N/A
0.14
+8%
0.05
-64%
-0.28
N/A
-0.23
+18%
-0.06
+74%

See Also

Discover More